Skip to main navigation Skip to search Skip to main content

Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter

Research output: Contribution to journalJournal articleResearch

Original languageEnglish
JournalThe Journal of Clinical Endocrinology & Metabolism
Volume88
Pages (from-to)6113-6114
ISSN0021-972X
DOIs
Publication statusPublished - 2003

Cite this